Biotech · Private company
Lyra Therapeutics
Track this companyFree. Adds Lyra Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- Background therapyPhase 3 · Chronic SinusitisClinicalTrials.gov · fetched Nov 12, 2026
- LYR-210Phase 3 · Chronic SinusitisClinicalTrials.gov · fetched Nov 12, 2026
- Sham procedure controlPhase 3 · Chronic SinusitisClinicalTrials.gov · fetched Nov 12, 2026
- Bilateral sham procedure control (Part 2)Phase 2 · Chronic SinusitisClinicalTrials.gov · fetched Nov 12, 2026
- LYR-220 Design 1 (Part 1 only)Phase 2 · Chronic SinusitisClinicalTrials.gov · fetched Nov 12, 2026
- LYR-220 Design 2 (Part 1 and Part 2)Phase 2 · Chronic SinusitisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults (ENLIGHTEN 2)PHASE3 · COMPLETED · started May 13, 2022ClinicalTrials.gov NCT05295459 · fetched Nov 12, 2026
- Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in AdultsPHASE3 · COMPLETED · started Jan 27, 2022ClinicalTrials.gov NCT05219968 · fetched Nov 12, 2026
- LYR-220 for Adult Subjects With Chronic Rhinosinusitis (BEACON Study)PHASE2 · COMPLETED · started Nov 23, 2021ClinicalTrials.gov NCT05035654 · fetched Nov 12, 2026